HOME
SEARCH
RSS FEED
SUBSCRIBE
Hybridoma Cell Line H1.2F3 Producing Monoclonal Anti-mouse CD69 (Early activation marker) Antibody
Case ID:
TAB-3192
Web Published:
12/6/2022
Description:
A hybridoma cell line producing a monoclonal hamster antibody specific to mouse CD69 (early activation marker) (clone H1.2F3) as described in J Immunol. 1988 Jul 15;141(2):369-76 and developed by the laboratory of Dr. Ethan Shevach at the National Institute of Allergy and Infectious Diseases.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Patent Status
Direct Link:
https://nih.technologypublisher.com/tech/Hybridoma_Cell_Line_H1.2F3_Producing _Monoclonal_Anti-mouse_CD69_(Early_activation_marker)_Antibody
Category(s):
Licensing
Research Materials
Bookmark this page
Download as PDF
For Information, Contact:
Yogikala Prabhu
Technology Transfer Patent Specialist
NIH Technology Transfer
+1 240 276 5530
yogikala.prabhu@nih.gov
Inventors:
Ethan Shevach
Keywords:
141:369-376
1988
AC5XXX
Cell
H12F3
Hybridoma
Immunology
J.
Line
Listed LPM Nguyen-Antczak as of 4/15/2015
Mab
Post LPM Assignment Set 20150420
Pre LPM working set 20150418
RM
WIXXXX
Home
|
Search
|
RSS
|
Subscribe
© 2024. All Rights Reserved. Powered by
Inteum